Article Text

Download PDFPDF
Letter
Explant rates of neuromodulation devices: supplemental information—reply to Mukhdomi and Harris

Statistics from Altmetric.com

PDF extract preview

You do not have access to the full text of this article, the first page of the PDF of this article appears above.

Footnotes

  • Contributors JR drafted the article and performed statistical analysis. All authors read and accepted the final version of the letter.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests AA-K is an investigator with Nevro, Boston Scientific, Abbott and Medtronic and has stock in Micron LLC. SP is and investigator with Saluda Medical. TLY is a consultant with Boston Scientific, an investigator with Nevro, Abbott and Boston Scientific and chief medical officer of Meghan Medical.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles